The results showed that the cluster 3 subgroup of STAD patients was accompanied by a low TP53 mutation rate and a high LRP1B mutation rate, suggesting a potential upstream mechanism for the poor prognosis and increased infiltration of non-tumor components of cluster 3 (Figures 3A, B). This evidence concerns the gene TP53 and neoplasm.